Medx Health

Medx Health Current Assets

The Current Assets of Medx Health (MDX.V) as of Oct 21, 2026 is 188,219.00 CAD. In the previous year, Current Assets was 670,326.00 CAD — a change of -71.92% (lower).

Current Assets

188,219.00CAD

YoY

-71.92%

Last updated:

Current Assets of Medx Health is 2025 188,219.00 CAD. Current Assets of Medx Health was 2024 670,326.00 CAD. It decreases by -71.92% lower compared to the previous year.

The Medx Health Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
423,017.00 CAD
Jan 1, 2019
292,368.00 CAD
Jan 1, 2020
414,556.00 CAD
Jan 1, 2021
380,806.00 CAD
Jan 1, 2022
422,276.00 CAD
Jan 1, 2023
449,722.00 CAD
Jan 1, 2024
670,326.00 CAD
Jan 1, 2025
188,219.00 CAD
The Medx Health Current Assets history
YEARCurrent AssetsYoY
188,219.00CAD-71.92%
670,326.00CAD+49.05%
449,722.00CAD+6.50%
422,276.00CAD+10.89%
380,806.00CAD-8.14%
414,556.00CAD+41.79%
292,368.00CAD-30.89%
423,017.00CAD+62.43%
260,430.00CAD+18.54%
219,704.00CAD+71.89%
127,814.00CAD-40.72%
215,610.00CAD+14.07%
189,017.00CAD-27.30%
260,000.00CAD-44.68%
470,000.00CAD+104.35%
230,000.00CAD-23.33%
300,000.00CAD-74.36%
1.17 MCAD+58.11%
740,000.00CAD-36.75%
1.17 MCAD-36.41%
1.84 MCAD+58.62%
1.16 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medx Health Stock analysis

What does Medx Health do? MedX Health Corp develops and sells medical devices and software focused on skin health. Its core products include SIAscopy technology for scanning skin moles and lesions, integrated with the DermSecure telemedicine platform. The company manufactures hand-held devices like SIAMETRICS, SIMSYS, and MoleMate, which use light-based technology to detect skin issues up to two millimeters beneath the surface without pain or invasion. These devices are used in dermatology clinics and rehabilitation centers for early skin cancer detection and non-invasive treatment of pain and tissue damage. The company's telemedicine platform, SIAscopy on DermSecure, enables remote operation of its scanning technology through web-based services. Phototherapy devices utilizing lower-level laser and LED light energy are sold to healthcare providers for pain relief and tissue repair in rehabilitation settings. The primary customers are dermatologists, clinics specializing in skin health, and rehabilitation facilities seeking non-invasive diagnostic and treatment solutions. MedX Health Corp generates revenue through direct sales of its medical devices, telemedicine software, and phototherapy equipment. The SIAscopy technology and associated products are marketed to healthcare professionals in the dermatology and rehabilitation sectors. The company's focus on skin screening and pain-free tissue repair drives sales of its hand-held devices and telemedicine platform to medical institutions requiring advanced diagnostic tools. Medx Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medx Health stock

Current Assets of Medx Health is 188,219.00 CAD in 2025.

Current Assets of Medx Health changed from 670,326.00 CAD to 188,219.00 CAD, representing a -71.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Medx Health since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Medx Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Medx Health

All Key Metrics — Medx Health